Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MedX Health ( (TSE:MDX) ) has provided an announcement.
In 2025, MedX Health Corp. invested over CAD$2 million to enhance its technology platform and operational infrastructure, preparing for a large-scale rollout in 2026. The company expanded its DermSecure® Platform, appointed new executive leadership, and entered a commercial agreement with Health Partners Group. Additionally, MedX’s Photobiomodulation division launched new laser lines, broadening its market reach, while its SIAscopy® technology continued to serve major Contract Research Organizations, supporting future product enhancements.
More about MedX Health
MedX Health Corp. is a data-driven health analytics company specializing in proprietary imaging, Teledermatology, and Photobiomodulation systems. It operates as an ISO 13485–certified medical device manufacturer, complying with various international regulatory frameworks, and focuses on generating and analyzing high-fidelity skin health data.
Average Trading Volume: 124,595
Technical Sentiment Signal: Sell
Current Market Cap: C$16.6M
See more insights into MDX stock on TipRanks’ Stock Analysis page.